Skip to main content
Premium Trial:

Request an Annual Quote

AnVil, ClinQuest in Consulting Partnership

NEW YORK, May 16-The Massachusetts bioinformatics company AnVil has struck a partnership with healthcare and biotech consulting company ClinQuest by which the two companies will refer clients to one another.

 

For ClinQuest customers, AnVil will offer tools to analyze and visualize complex data sets. AnVil also becomes part of ClinQuest's consultant network.

 

AnVil customers will be referred to ClinQuest for product development, clinical trial, market research and regulatory issues consulting.

 

ClinQuest, based in Marlborough, Mass., provides consulting expertise to biotechnology, pharmaceutical, and medical diagnostic firms.

 

AnVil, based in Burlington, Mass., is privately owned.

 

Click here for more information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.